BioNTech SE is 1.2x more valuable than Moderna, Inc. by market capitalization ($22.18 B vs $18.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRNA | BNTX |
|---|---|---|
| Market cap | $18.86 B | $22.18 B |
| US-listed rank | #643 | #582 |
| Revenue (latest FY) | $1.94B | - |
| Net income (latest FY) | -$2.82B | - |
| Net margin | -145.2% | - |
| SEC filings | 1,447 | 548 |
BioNTech SE is 1.2x more valuable than Moderna, Inc. by market capitalization ($22.18 B vs $18.86 B).
Full pages: Moderna, Inc. and BioNTech SE, or browse the full rankings.